These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23966782)

  • 1. Nanolipodendrosome-loaded glatiramer acetate and myogenic differentiation 1 as augmentation therapeutic strategy approaches in muscular dystrophy.
    Afzal E; Zakeri S; Keyhanvar P; Bagheri M; Mahjoubi P; Asadian M; Omoomi N; Dehqanian M; Ghalandarlaki N; Darvishmohammadi T; Farjadian F; Golvajoee MS; Afzal S; Ghaffari M; Cohan RA; Gravand A; Ardestani MS
    Int J Nanomedicine; 2013; 8():2943-60. PubMed ID: 23966782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved muscle strength and mobility in the dy(2J)/dy(2J) mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate.
    Dadush O; Aga-Mizrachi S; Ettinger K; Tabakman R; Elbaz M; Fellig Y; Yanay N; Nevo Y
    Neuromuscul Disord; 2010 Apr; 20(4):267-72. PubMed ID: 20304648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
    Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
    Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.
    Wanschitz JV; Dubourg O; Lacene E; Fischer MB; Höftberger R; Budka H; Romero NB; Eymard B; Herson S; Butler-Browne GS; Voit T; Benveniste O
    Neuromuscul Disord; 2013 Jan; 23(1):75-83. PubMed ID: 23058947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A.
    Kumar A; Yamauchi J; Girgenrath T; Girgenrath M
    Hum Mol Genet; 2011 Jun; 20(12):2333-43. PubMed ID: 21441569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery.
    Abujarour R; Bennett M; Valamehr B; Lee TT; Robinson M; Robbins D; Le T; Lai K; Flynn P
    Stem Cells Transl Med; 2014 Feb; 3(2):149-60. PubMed ID: 24396035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration.
    Jin Y; Murakami N; Saito Y; Goto Y; Koishi K; Nonaka I
    Acta Neuropathol; 2000 Jun; 99(6):619-27. PubMed ID: 10867795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nandrolone stimulates MyoD expression during muscle regeneration in the condition of myonecrosis induced by Bothrops jararacussu venom poisoning.
    Wagner Alves de Souza R; Gonçalves W; Garrido Cavalcante WL; Pai-Silva MD; Gallacci M
    J Toxicol Environ Health A; 2010; 73(13-14):934-43. PubMed ID: 20563927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mitochondrial micropeptide MPM enhances mitochondrial respiratory activity and promotes myogenic differentiation.
    Lin YF; Xiao MH; Chen HX; Meng Y; Zhao N; Yang L; Tang H; Wang JL; Liu X; Zhu Y; Zhuang SM
    Cell Death Dis; 2019 Jul; 10(7):528. PubMed ID: 31296841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.
    Kimura E; Han JJ; Li S; Fall B; Ra J; Haraguchi M; Tapscott SJ; Chamberlain JS
    Hum Mol Genet; 2008 Aug; 17(16):2507-17. PubMed ID: 18511457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear changes in skeletal muscle extend to satellite cells in autosomal dominant Emery-Dreifuss muscular dystrophy/limb-girdle muscular dystrophy 1B.
    Park YE; Hayashi YK; Goto K; Komaki H; Hayashi Y; Inuzuka T; Noguchi S; Nonaka I; Nishino I
    Neuromuscul Disord; 2009 Jan; 19(1):29-36. PubMed ID: 19070492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles.
    McIntosh LM; Garrett KL; Megeney L; Rudnicki MA; Anderson JE
    Anat Rec; 1998 Oct; 252(2):311-24. PubMed ID: 9776086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
    Katagiri T; Akiyama S; Namiki M; Komaki M; Yamaguchi A; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T
    Exp Cell Res; 1997 Feb; 230(2):342-51. PubMed ID: 9024793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies.
    Onofre-Oliveira PC; Santos AL; Martins PM; Ayub-Guerrieri D; Vainzof M
    Neuromolecular Med; 2012 Mar; 14(1):74-83. PubMed ID: 22362587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expressions of myogenic markers in skeletal muscle differentiation of human bone marrow mesenchymal stem cells].
    Liu TY; Dai H; Lin J; Li M; Xiong F; Feng SW; Zhang YN; Zhang C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Oct; 32(5):516-20. PubMed ID: 21054957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training improves the oxidative phenotype of muscle during the transition from cardiac hypertrophy to heart failure without altering MyoD and myogenin.
    Pacagnelli FL; Aguiar AF; Campos DH; Castan EP; de Souza RW; de Almeida FL; Carani F; Carvalho RF; Cicogna AC; Silva MD
    Exp Physiol; 2016 Aug; 101(8):1075-85. PubMed ID: 27219629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
    Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
    Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy
    Rabie M; Yanay N; Fellig Y; Konikov-Rozenman J; Nevo Y
    Clin Neurophysiol; 2019 Oct; 130(10):1988-1994. PubMed ID: 31476705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nerve-regulated genes in muscles of mouse mutants affected by spinal muscular atrophies and muscular dystrophies.
    Sedehizade F; Klocke R; Jockusch H
    Muscle Nerve; 1997 Feb; 20(2):186-94. PubMed ID: 9040657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Nandrolone in the Counteraction of Skeletal Muscle Atrophy in a Mouse Model of Muscle Disuse: Molecular Biology and Functional Evaluation.
    Camerino GM; Desaphy JF; De Bellis M; Capogrosso RF; Cozzoli A; Dinardo MM; Caloiero R; Musaraj K; Fonzino A; Conte E; Jagerschmidt C; Namour F; Liantonio A; De Luca A; Conte Camerino D; Pierno S
    PLoS One; 2015; 10(6):e0129686. PubMed ID: 26066046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.